We are live on
!
Find out more
CORV
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV
Delisted
CORV was delisted on the 26th of May, 2020.
27 hedge funds and large institutions have $27.3M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
13% less funds holding
Funds holding: 31 → 27 (-4)
30% less capital invested
Capital invested by funds: $38.7M → $27.3M (-$11.5M)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Holders
27
Holders Change
-4
Holders Change %
-12.9%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
9
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$528K |
| 2 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$201K |
| 3 |
Renaissance Technologies
New York
|
+$121K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$47.1K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$29.2K |
